Horizon Discovery and Domainex Ltd Collaborate to Support Lead Optimization Oncology Program. Horizon’s isogenic cell lines accurately modeling tumor mutations to be used to profile lead compounds.

Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled Peptides

RCUK Shared Services Centre Ltd extends contract with Cambridge Research Biochemicals

Cambridge Research Biochemicals Signs Exclusive Japanese Distribution Deal with BioBridge

UCB and Domainex collaboration provides valuable information on cancer drug target using CDH technology.

Xceleron Announces New Investment And Move To Purpose-Built Laboratories In U.S. Demand in translational science drives need for additional equipment

Cambridge Research Biochemicals signs agreement with Life Technologies to offer custom dye labelled antibodies.

Domainex Awarded Technology Strategy Board Funding to Support its Research into a Novel Cancer Drug

The Early Symptoms of Alzheimer’s website has been launched on World Alzheimer’s day www.earlysymptomsalzheimers.com